Overview

Quantitative proteomics aims to measure changes in protein abundance across different biological conditions. Unlike qualitative identification, which merely establishes the presence of a protein, quantification reveals how the proteome responds to stimuli, disease, or treatment. Two broad strategies dominate the field: label-based methods that introduce stable isotope tags into proteins or peptides, and label-free methods that infer abundance from spectral counts or ion intensities. Each approach carries trade-offs between accuracy, multiplexing capacity, cost, and experimental complexity, making the choice of method highly dependent on the biological question being asked.

Methods

Stable isotope labeling techniques include SILAC (metabolic labeling in cell culture), TMT and iTRAQ (isobaric tags for relative and absolute quantification), and dimethyl labeling. These introduce defined mass shifts that the mass spectrometer can distinguish, allowing multiplexed analysis of up to 16 samples in a single run. Label-free quantification uses either the number of identified spectra (spectral counting) or the extracted ion chromatogram area of each peptide (MS1 intensity). Data-independent acquisition (DIA) methods such as SWATH-MS combine deep proteome coverage with quantitative precision across large sample cohorts.

Applications

Quantitative proteomics is widely applied in biomarker discovery, comparing protein levels between healthy and diseased tissues to identify diagnostic or prognostic signatures. In drug development, it profiles target engagement and off-target effects. The integration of quantitative data with ELISA and Western blot validation ensures robustness. Methods such as mass spectrometry-based quantification complement traditional gel-based approaches like SDS-PAGE, providing deeper coverage and higher throughput.